GridAI Technologies (GRDX) Acquisitions (2024 - 2025)
GridAI Technologies' (GRDX) quarterly Acquisitions came in at -$12945.0 in Q4 2025, down 114.68% on a QoQ basis from $88169.0 in Q1 2024.
GridAI Technologies (GRDX) Acquisitions (2024 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 2 years of Acquisitions data on file, last reported at -$12945.0 in Q4 2025.
- Quarterly Acquisitions changed N/A year-over-year to -$12945.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12945.0 (down 114.68% YoY) and the FY2025 annual result came in at $323482.0, up 266.89% from the prior year.
- Acquisitions fell to -$12945.0 in Q4 2025, from $88169.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $88169.0 in Q1 2024 to a low of -$12945.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | GridAI Technologies | 6.45 Mn | 6.45 Mn | - | -12,945.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,945.00 |
| Mar 31, 2024 | 88,169.00 |